WSJ: Should MRI to detect prostate cancer become standard of care?

A growing body of evidence proves MRI can effectively identify suspicious lesions prior to biopsy. MRI generally does not detect indolent tumors that do not require treatment and can guide biopsy needles for more precise targeting. This reduces the necessity for repeat biopsies while increasing detection rates for high-risk, high-grade prostate cancers. However, the practice of using MRI to detect … Read More